As shown above, circulating ox-LDL levels, also associated with metabolic disorders [17], were increased in obese patients, remained high after weight loss (Table 1A) and correlated negatively with IRAK3 expression in monocytes (rs = −0.32, P<0.05). The gene discussed is IRAK3; the disease is metabolic disease.